Research Article

Granulovacuolar Degeneration in Hippocampus of Neurodegenerative Diseases: Quantitative Study

Table 3

The table shows the means and standard deviations for the individuals with neurodegenerative diseases and controls.

ā€‰ā€‰CA4CA3CA2CA1
CasesMeanSDMeanSDMeanSDMeanSD

AD562.65.16372.3564.59804.9455.749817.08910.9065
AD/LBD94.5036.45484.1455.53968.0846.067718.0139.8355
AGD21.1960.17010.9501.34433.2071.207712.9376.6612
CBD41.2261.66082.6923.26994.8534.84858.344.5758
Control700.8652.73500.9494.03311.8272.95554.8326.3212
FTLD-U100.4450.66290.5220.79760.7971.02811.8651.9706
LBD100.8831.20361.7592.64804.2064.36403.7883.8121
MSA50.1170.263100.00001.3390.98870.4120.8307
PD30.1790.31040.4270.40811.3331.80741.9560.1378
PiD21.0261.45050.8191.15921.5622.20974.0625.7452
PSP101.7152.80282.7355.02615.1946.00625.4017.5781